Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by SCHAIRER, C.
Right arrow Articles by HOOVER, R. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SCHAIRER, C.
Right arrow Articles by HOOVER, R. N.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

American Journal of Epidemiology Vol. 124, No. 4: 603-611
Copyright © 1986 by The Johns Hopkins University School of Hygiene and Public Health

research-article

METHYLXANTHINES AND BENIGN BREAST DISEASE1

CATHERINE SCHAIRER2, LOUISE A. BRINTON and ROBERT N. HOOVER

Reprint requests to Catherine Schairer, Environmental Epidemiology Branch, National Cancer Institute, National Institutes of Health, Landow Building, Room 3C-06, Bethesda, MD 20892

The relation between methylxanthine consumption and biopsied benign breast disease was investigated by using data from a case-control study which included 1,569 cases and 1,846 controls identified between 1973 and 1980 through a nationwide screening program. There was no evidence of an association between methylxanthine consumption and benign breast disease in the total study population. When histologic types of benign breast disease were examined, there were no trends in risk according to methylxanthine consumption among the 813 cases with fibrocystic disease, the 508 cases for whom detailed pathology data were not available, the 172 cases with benign neoplasms, or the 156 cases with other benign conditions. When cases with fibrocystic disease were examined according to presence of atypia, hyperplasia, sclerosing adenosis, or cysts, there was, again, no association between methylxanthine consumption and risk of disease. In addition, no relation was found between methylxanthine consumption and menstrual breast tenderness among premenopausal women with fibrocystic disease or unknown conditions.

breast neoplasms; coffee; fibrocystic disease of breast

1 Environmental Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
P. M. Webb, C. Byrne, S. J. Schnitt, J. L. Connolly, T. W. Jacobs, H. J. Baer, W. C. Willett, and G. A. Colditz
A Prospective Study of Diet and Benign Breast Disease
Cancer Epidemiol. Biomarkers Prev., July 1, 2004; 13(7): 1106 - 1113.
[Abstract] [Full Text] [PDF]

Home page
 Am J EpidemiolHome page
J. Brown, N. Kreiger, G. A. Darlington, and M. Sloan
Misclassification of Exposure: Coffee as a Surrogate for Caffeine Intake
Am. J. Epidemiol., April 15, 2001; 153(8): 815 - 820.
[Abstract] [Full Text] [PDF]

Home page
 Int J EpidemiolHome page
C. Friedenreich, H. Bryant, F Alexander, J Hugh, J Danyluk, and D. Page
Risk factors for benign proliferative breast disease
Int. J. Epidemiol., August 1, 2000; 29(4): 637 - 644.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.